Clarity Pharmaceuticals Ltd
OTC:CLRPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clarity Pharmaceuticals Ltd
OTC:CLRPF
|
AU |
|
M
|
Mitie Group PLC
F:MZ4
|
UK |
|
B
|
Banco Santander SA
XHAM:BSD2
|
ES |
Intrinsic Value
The intrinsic value of Clarity Pharmaceuticals Ltd (CLRPF) under the Base Case is 1.916 USD per share. Compared with the current market price of 1.115 USD, the stock appears Undervalued by 42% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Clarity Pharmaceuticals Does
Clarity Pharmaceuticals is a radiopharmaceutical company that develops drugs used in medical imaging and cancer treatment. Its main idea is to attach copper-based radioactive isotopes to targeting molecules so doctors can see tumors more clearly on scans or deliver radiation directly to cancer cells.
- Headquarters
- Australia AU
- IPO date
- Aug 25, 2021
Earnings Waterfall
Clarity Pharmaceuticals Ltd
The intrinsic value for Clarity Pharmaceuticals Ltd (CLRPF) under the Base Case is 1.916 USD.
Compared with the current market price of 1.115 USD, the stock appears Undervalued by 42% .